FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

18291111000001107: Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62641801000001110 Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62641901000001116 Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
68870201000001119 Renvela 800mg tablets (Sanofi) 180 tablet en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
68875801000001113 Renvela 800mg tablets (Sanofi) 180 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet Is a Sevelamer 800mg tablets 180 tablet true Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet Has AMP Renvela 800mg tablets (Genzyme Therapeutics Ltd) true Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Renvela 800mg tablets (Genzyme Therapeutics Ltd) 180 tablet Has specific active ingredient Sevelamer true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start